SEC Filing Summary: MRI Interventions, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by MRI Interventions, Inc. on May 8, 2012. The report discloses the execution of a Separation Agreement with a former executive officer. Note: The request metadata references "Clearpoint Neuro, Inc.," but the filing text explicitly identifies the registrant as "MRI Interventions, Inc."
Key Financial Metrics
This filing does not contain comprehensive financial statements, revenue, profit, cash flow, or debt metrics. The only specific financial figure disclosed is a one-time separation payment of $27,500 to the departing executive.
Material Changes
- Executive Departure: John T. Keane, Vice President of Sales and a named executive officer, terminated his employment effective April 16, 2012.
- Separation Terms: A Separation Agreement dated May 8, 2012, was executed. It provides for a cash payment of $27,500 to be paid in three installments.
- Legal Obligations: The agreement includes a release of claims and reaffirms the enforceability of existing Non-Disclosure and Non-Competition agreements dated March 17, 2010.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on business outlook, or discussion of general corporate risks. The primary contingency noted is that the departing executive may revoke the release of claims until May 15, 2012; if revoked, the separation benefits will not be paid.
Investor Verification Checklist
- Verify the identity of the registrant (MRI Interventions, Inc.) versus the metadata name (Clearpoint Neuro, Inc.).
- Confirm the status of the release of claims by May 15, 2012, to determine if the $27,500 payment obligation remains valid.
- Review the full text of the Separation Agreement (Exhibit 10.1) for additional terms not summarized in the report.
- Assess the operational impact of the departure of the Vice President of Sales on the company's commercial strategy.